Pseudo deep-vein thrombosis following desferrioxamine infusion: a previously unreported adverse reaction?

Establishing local reference intervals for full blood count and white blood cell differential counts in Cape Town, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021

Biochemical storage lesions occurring in nonirradiated and irradiated red blood cells: a brief review.

BioMed research international·2015

The clinical and pathological features of gastric impaction in twelve horses.

Equine veterinary journal. Supplement·2013

Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics.

Beneficial microbes·2011

Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma.

Current oncology (Toronto, Ont.)·2010

Transfer chemical laser: modeling of a cw DF-CO(2) laser.

Applied optics·2010

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Current landscape of drug induced retinal vasculitis.

Journal of ophthalmic inflammation and infection·2026

Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

Expert review of gastroenterology & hepatology·2026

AA Renal amyloidosis associated with a gastrointestinal stromal tumor.

Nefrologia·2026

Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review.

Molecular genetics and metabolism·2026

IL-15 drives antigen-independent increase in granzyme K+B+ CD8 T cells enriched in rheumatoid arthritis joints.

Journal of autoimmunity·2026

Re-evaluating the role of IL-1Ra gene therapy in knee osteoarthritis: a case for autologous conditioned serum as a practical alternative.

Connective tissue research·2026

Related Experiment Videos

Pseudo deep-vein thrombosis following desferrioxamine infusion: a previously unreported adverse reaction?

Related Concept Videos

Establishing local reference intervals for full blood count and white blood cell differential counts in Cape Town, South Africa.

Biochemical storage lesions occurring in nonirradiated and irradiated red blood cells: a brief review.

The clinical and pathological features of gastric impaction in twelve horses.

Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics.

Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma.

Transfer chemical laser: modeling of a cw DF-CO(2) laser.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Current landscape of drug induced retinal vasculitis.

Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

AA Renal amyloidosis associated with a gastrointestinal stromal tumor.

Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review.

IL-15 drives antigen-independent increase in granzyme K+B+ CD8 T cells enriched in rheumatoid arthritis joints.

Re-evaluating the role of IL-1Ra gene therapy in knee osteoarthritis: a case for autologous conditioned serum as a practical alternative.

Related Experiment Videos

Pseudo deep-vein thrombosis following desferrioxamine infusion: a previously unreported adverse reaction?

Related Concept Videos

Related Articles